{"id":"W2587875644","doi":"10.1136/gutjnl-2016-312735","title":"Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials","year":2017,"lang":"en","type":"article","venue":"Gut","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":361,"is_retracted":false,"has_abstract":true,"ca_institutions":"Robarts Clinical Trials; University of Calgary","funders":"Pfizer; GlaxoSmithKline; Amgen; American College of Gastroenterology; Eli and Edythe Broad Foundation","keywords":"Tofacitinib; Placebo; Crohn's disease; Medicine; Internal medicine; Maintenance therapy; Clinical trial; Physical therapy; Disease; Alternative medicine; Pathology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01811421,0.002339536,0.006654224,0.0007432628,0.0006569583,0.002629591,0.001606881,0.00581227,0.006936457],"category_scores_gemma":[0.01575652,0.001158653,0.005216734,0.001209727,0.001352108,0.00178964,0.0006310134,0.003043114,0.0008468215],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001564825,"about_ca_system_score_gemma":0.001898727,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008156014,"about_ca_topic_score_gemma":0.001323411,"domain_scores_codex":[0.9921724,0.00482877,0.001113893,0.0007012952,0.0007291444,0.0004544254],"domain_scores_gemma":[0.9912623,0.003601904,0.002795757,0.0005683365,0.000886485,0.0008852591],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.954785,0.00159748,0.0006428476,0.00581836,0.005115969,0.00003656141,0.00007970917,0.0001275981,0.001830967,0.00009213435,0.001027367,0.02884581],"study_design_scores_gemma":[0.9747294,0.01750852,0.00210528,0.0005109409,0.003405147,0.00003599194,0.00001851885,0.0000963116,0.0002432269,0.00007806882,0.001251733,0.00001687944],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5855848,0.3574621,0.005029406,0.006663656,0.003853231,0.02662019,0.005757317,0.0004717144,0.008557528],"genre_scores_gemma":[0.8401265,0.1049668,0.007156175,0.007839178,0.003778179,0.02650839,0.00544153,0.000122827,0.004060565],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01811421,"threshold_uncertainty_score":0.09579825,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03372392994722092,"score_gpt":0.3415235518266941,"score_spread":0.3077996218794732,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}